<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">


<journal>
<language>en</language>
<journal_id_issn>1726-7536</journal_id_issn>
<journal_id_issn_online>1735-8507</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_isnet></journal_id_isnet>
<journal_id_iranmedex>69</journal_id_iranmedex>
<journal_id_magiran>2139</journal_id_magiran>
<journal_id_sid>288</journal_id_sid>
<pubdate PubStatus="epublish">
	<type>gregorian</type>
	<year>2022</year>
	<month>10</month>
	<day>26</day>
</pubdate>
<volume>23</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>36452192</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Estimation of Serum and Seminal Plasma Levels of Glactin-1 in Non-Obstructive Azoospermia Cases and Their Correlations with the Rate of Sperm Retrieval: A Comparative Prospective Study</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: Remarkably, the current study is one of the first to deploy galectin-1 (Gal-1) in determining the degree of impairment of spermatogenesis among cases with non-obstructive azoospermia (NOA) as well as utilizing it as a biomarker to predict the rate of sperm retrieval in these patients. The purpose of the study was to evaluate the seminal plasma and serum levels of Gal-1 in NOA patients as well as their correlations with Johnsen&amp;rsquo;s tubular biopsy scoring (JTBS).&lt;br /&gt;
Methods: The current case control study included totally 48 patients with NOA whose ages ranged from 24 to 46 years old and 50 age matched healthy controls. Gal-1 levels were measured in both seminal plasma and serum of all subjects by the enzyme-linked immunosorbent assay (ELISA).&lt;br /&gt;
Results: A significant negative correlation between seminal plasma levels of Gal-1 and JTBS was detected (r=-0.281, p=0.048) in the NOA cases. Interestingly, the receiver operating characteristic (ROC) curve had demonstrated that the cutoff value of seminal plasma levels of Gal-1 in determining azoospermia was &amp;gt;0.735 ng/ml and the area under the curve (AUC) was 0.858. The sensitivity, specificity, positive predictive, and negative predictive values for seminal plasma levels of Gal-1 were 76, 92, 90.5, and 79.3, respectively. In addition, sensitivity, specificity, positive predictive, and negative predictive values for serum levels of Gal-1 were 38, 66, 52.8, and 51.6, respectively.&lt;br /&gt;
Conclusion: Seminal plasma levels of Gal-1 are higher in NOA men versus healthy controls. Interestingly, negative correlation of seminal plasma levels of Gal-1 with JTBS was determined. Thus, it can be used as a good predictor for NOA cases.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Non-obstructive azoospermia, Seminal plasma levels of Gal-1, Serum levels of Gal-1</keyword>
	<start_page>257</start_page>
	<end_page>264</end_page>
	<web_url>https://www.jri.ir/article/140162</web_url>
	<pdf_url>https://www.jri.ir/documents/fullpaper/en/140162.pdf</pdf_url>
	<author_list><author><first_name>Sameh Fayek</first_name><middle_name></middle_name><last_name>GamalEl Din</last_name><suffix></suffix><affiliation>Department of Andrology and STDs, Faculty of Medicine Kasralainy, Cairo University, Cairo, Egypt</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email>samehfayek@kasralainy.edu.eg</email><code>122433</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Khadiga</first_name><middle_name></middle_name><last_name>Abougabal</last_name><suffix></suffix><affiliation>Department of Clinical and Chemical Pathology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122434</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Hany Mohammed</first_name><middle_name></middle_name><last_name>Saad</last_name><suffix></suffix><affiliation>Department of Andrology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122435</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohamed</first_name><middle_name></middle_name><last_name>Mohamed</last_name><suffix></suffix><affiliation>Department of Andrology and STDs, Faculty of Medicine Kasralainy, Cairo University, Cairo, Egypt</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122436</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Amira Mahmoud</first_name><middle_name></middle_name><last_name>Mohamed Ali</last_name><suffix></suffix><affiliation>Egyptian Ministry of Health and Population, Cairo, Egypt</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122437</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ahmed</first_name><middle_name></middle_name><last_name>Abo Sief </last_name><suffix></suffix><affiliation>Department of Andrology and STDs, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122438</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

